These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Pulmonary side effects of bleomycin therapy]. Andler W Klin Padiatr; 1984; 196(1):47-8. PubMed ID: 6198554 [TBL] [Abstract][Full Text] [Related]
45. [Pulmonary toxicity of bleomycin in the rabbit: histophysiological and anatomo-radiological correlations]. Bellet-Barthas M; Le Roy JP; Barthelemy L; Bellet M Toxicol Eur Res; 1983 May; 5(3):113-6. PubMed ID: 6195768 [TBL] [Abstract][Full Text] [Related]
46. [Experimental studies of pulmonary changes induced by administration of bleomycin in the rat: preliminary report (proceedings)]. Bianchi A; Gandola L; Rognoni F; Servida E; Soccini F; Tansini G Radiol Med; 1977 Apr; 63(4):356-60. PubMed ID: 73203 [No Abstract] [Full Text] [Related]
47. Bleomycin-induced pulmonary fibrosis in a patient with rheumatoid arthritis. A possible synergistic effect? Aitken ML; Dugowson C; Schmidt RA; Fer M West J Med; 1989 Mar; 150(3):344-6. PubMed ID: 2472035 [No Abstract] [Full Text] [Related]
54. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Vyalov SL; Gabbiani G; Kapanci Y Am J Pathol; 1993 Dec; 143(6):1754-65. PubMed ID: 7504890 [TBL] [Abstract][Full Text] [Related]
55. [Probable pulmonary damage caused by bleomycin. Communication of 4 cases]. Arraztoa J; Oddó D; Cerda B; San Martin S Rev Med Chil; 1991 Nov; 119(11):1270-6. PubMed ID: 9723079 [TBL] [Abstract][Full Text] [Related]
56. Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis. Borzone G; Moreno R; Urrea R; Meneses M; Oyarzún M; Lisboa C Am J Respir Crit Care Med; 2001 Jun; 163(7):1648-53. PubMed ID: 11401889 [TBL] [Abstract][Full Text] [Related]
57. Cells containing factor XIIIa and pulmonary fibrosis induced by bleomycin. Toida M; Okumura Y; Takami T J Clin Pathol; 1991 Mar; 44(3):255-6. PubMed ID: 1707417 [TBL] [Abstract][Full Text] [Related]
58. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. Tran PL; Weinbach J; Opolon P; Linares-Cruz G; Reynes JP; Grégoire A; Kremer E; Durand H; Perricaudet M J Clin Invest; 1997 Feb; 99(4):608-17. PubMed ID: 9045862 [TBL] [Abstract][Full Text] [Related]
59. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Chandler DB; Hyde DM; Giri SN Am J Pathol; 1983 Aug; 112(2):170-7. PubMed ID: 6192723 [TBL] [Abstract][Full Text] [Related]
60. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model. Besnard AG; Struyf S; Guabiraba R; Fauconnier L; Rouxel N; Proost P; Uyttenhove C; Van Snick J; Couillin I; Ryffel B J Leukoc Biol; 2013 Dec; 94(6):1317-23. PubMed ID: 23975892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]